LEVOXINE levothyroxine sodium 50 micrograms tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

levoxine levothyroxine sodium 50 micrograms tablet bottle

sun pharma anz pty ltd - levothyroxine sodium, quantity: 0.05 mg - tablet - excipient ingredients: pregelatinised starch; magnesium stearate; hyprolose; microcrystalline cellulose; titanium dioxide; indigo carmine aluminium lake - levothyroxine sodium is indicated for the management of demonstrated thyroid hormone deficiency.,levothyroxine sodium is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

APO-LEVOTHYROXINE levothyroxine sodium 200 microgram un-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-levothyroxine levothyroxine sodium 200 microgram un-coated tablet blister pack

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.2 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

LEVOTHYROXINE LUP levothyroxine sodium 200 microgram un-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

levothyroxine lup levothyroxine sodium 200 microgram un-coated tablet blister pack

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.2 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

APO-LEVOTHYROXINE levothyroxine sodium 150 microgram un-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-levothyroxine levothyroxine sodium 150 microgram un-coated tablet blister pack

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.15 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

LEVOTHYROXINE LUP levothyroxine sodium 150 microgram un-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

levothyroxine lup levothyroxine sodium 150 microgram un-coated tablet blister pack

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.15 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

APO-LEVOTHYROXINE levothyroxine sodium 125 microgram un-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-levothyroxine levothyroxine sodium 125 microgram un-coated tablet blister pack

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.125 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

LEVOTHYROXINE LUP levothyroxine sodium 125 microgram un-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

levothyroxine lup levothyroxine sodium 125 microgram un-coated tablet blister pack

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.125 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

APO-LEVOTHYROXINE levothyroxine sodium 100 microgram un-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-levothyroxine levothyroxine sodium 100 microgram un-coated tablet blister pack

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.1 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

LEVOTHYROXINE LUP levothyroxine sodium 100 microgram un-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

levothyroxine lup levothyroxine sodium 100 microgram un-coated tablet blister pack

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.1 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

APO-LEVOTHYROXINE levothyroxine sodium 75 microgram un-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-levothyroxine levothyroxine sodium 75 microgram un-coated tablet blister pack

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.075 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.